Rubicon Research Ltd share price logo

Rubicon Research Ltd

NSE: RUBICON

BSE: 544578

Small Cap

Healthcare Sector

₹836.10

-20.10

(-2.35%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Rubicon Research Stock Performance

as on April 10, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹830.25
    ₹885.80
    downward going graph

    0.70%

    Downside

    5.94%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹570.75
    ₹885.80
    downward going graph

    31.74%

    Downside

    5.94%

    Upside

    downward going graph

Rubicon Research share price movements today

Previous Close
₹856.20
Open
₹868.30
Volume
5.77L
Upper Circuit
₹1,027.40
Lower Circuit
₹685.00
Day's Low - High
₹830.25 - ₹885.80
52 Week Low - High
₹570.75 - ₹885.80

Rubicon Research Historical Returns

1 Month Return
+ 8.53 %
3 Month Return
+ 26.9 %
1 Year Return
+ 36.29 %
3 Year Return
+ 36.29 %
5 Year Return
+ 36.29 %

Rubicon Research Fundamentals

as on April 10, 2026 at 4:01 pm IST

Market Cap

₹2,447.60 Cr

Return on Equity (ROE)

13.19

PE Ratio (TTM)

0

Return on capital employed (ROCE)

16.64

Industry PE ratio

40.8

Beta (LTM)

0.44

P/B Ratio

2.47

Dividend Yield

0

PEG Ratio

0

Quarterly Earnings Growth YOY

91.23

EPS (TTM)

0

Sector

Pharmaceuticals

Book Value

0

Technical Analysis

Bullish

View Technical Analysis

Rubicon Research Stock Valuation

as on April 10, 2026 at 4:01 pm IST

Rubicon Research in the last 5 years

  • Overview

  • Trends

Lowest (49.58x)

January 23, 2026

Industry (40.80x)

April 9, 2026

Today (65.31x)

April 9, 2026

Highest (66.56x)

November 17, 2025

LowHigh

Today’s Price to Earnings Ratio: 65.31x

Rubicon Research Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Rubicon Research with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Novartis India Ltd image
Novartis India Ltd
NA2,447.6014.18%0.00100390
Titan Biotech Ltd image
Titan Biotech Ltd
NA1,876.89193.56%0.5118156
Kilitch Drugs (India) Ltd image
Kilitch Drugs (India) Ltd
BUY458.944.83%0.6024198
Alpa Laboratories Ltd image
Alpa Laboratories Ltd
NA145.948.51%0.5019112
Kwality Pharmaceuticals Ltd image
Kwality Pharmaceuticals Ltd
NA1,557.21535.83%0.6539370
See all

Market expectation of Rubicon Research Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Rubicon Research Stock’s Investor Sentiment and Interest

Search interest for Rubicon Research Ltd Stock has decreased by -44% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-44% versus previous 30 day period

Rubicon Research Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Sales
316.72
296.01
313.4
358.15
352.49
412.02
475.53
Other Income
0.39
2.66
0.49
0.1
0.63
0.7
3.79
Total Income
317.1
298.67
313.89
358.25
353.13
412.72
479.32
Expenses
256.49
234.35
243.5
285.67
273.38
317.72
367.4
Operating Profit
60.23
61.66
69.9
72.48
79.11
94.3
108.13
Operating Profit Margin %
19.02%
20.83%
22.3%
20.24%
22.44%
22.89%
22.74%
Profit Before Interest, Tax and Depreciation
60.61
64.32
70.39
72.57
79.74
94.99
111.91
Interest
10.09
7.02
7.82
11.85
10.62
11.42
9.77
Depreciation
9.36
8.15
9.42
9.66
9.57
11.87
11.55
Profit Before Tax
41.16
49.15
53.15
51.06
59.55
71.7
90.59
Tax Paid
15.6
14.68
15.08
14.81
16.25
17.85
17.79
Profit After Tax
25.57
34.48
38.07
36.25
43.3
53.85
72.8
Total Net profit including share of profit / Loss from associate company
25.57
34.48
38.07
36.25
43.3
53.85
72.8
EPS
1.66
2.27
2.5
2.35
2.81
3.49
4.46
Actual EPS
1.66
2.27
2.5
2.35
2.81
3.49
4.46
Adjusted EPS
1.66
2.27
2.5
2.35
2.81
3.49
4.46
Diluted EPS
-
2.23
2.46
-
2.79
3.47
4.41

Rubicon Research Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
313.57
393.52
853.89
1,284.27
Other Income
16.85
25.48
18.5
3.63
Total Income
330.42
419
872.39
1,287.91
Expenses
352.8
375.03
699.3
1,020.01
Operating Profit
-39.23
18.49
154.59
264.26
Operating Profit Margin %
-12.51%
4.7%
18.1%
20.58%
Profit Before Interest, Tax and Depreciation
-22.38
43.97
173.09
267.89
Interest
9.72
18.96
31.26
36.78
Depreciation
34.01
36.06
38.97
36.59
Profit Before Tax
-66.11
-11.05
102.86
194.52
Tax Paid
1.01
5.84
11.85
60.16
Profit After Tax
-67.12
-16.89
91.01
134.36
Total Net profit including share of profit / Loss from associate company
-67.12
-16.89
91.01
134.36
EPS
-4.41
-1.11
5.98
8.82
Actual EPS
-4.41
-1.11
5.98
8.82
Adjusted EPS
-0.15
-0.04
5.98
8.82
Diluted EPS
-4.41
-1.11
5.91
8.68

Rubicon Research Ltd Cash Flow

Figures in Rupees Crores

Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
5.47
61.67
-62.63
-74.75
21.01
159.18
Cash Flow from Investing Activities
-25.29
25.2
8.59
12.16
-12.24
5.23
Cash Flow from Financing Activities
80.07
51.5
63.04
122.82
43.55
-39.8
Net Cash Flow
1.21
67.08
-45.49
15.76
-3.82
54.37

Rubicon Research Stock Shareholding Pattern

Numbers in percentages

Jul 2024
Sep 2025
Oct 2025
Dec 2025
Promoters
84.15%
59.99%
59.99%
59.99%
DII
0%
10.54%
10.54%
9.45%
FII
0%
9.37%
9.37%
8%
Public
0%
20.1%
20.1%
22.57%
Total Outstanding Shares
15,20,99,340
16,47,50,309
16,47,50,309
16,47,50,309
Total Shareholders
15
1,05,311
1,05,311
31,914

Mutual Funds that own Rubicon Research Stock

Check out the Mutual Funds with significant holdings in Rubicon Research.

Rubicon Research Corporate Actions

View detailed summary of the earnings and dividend history of Rubicon Research.

  • Rubicon Research Ltd Earnings Results

    Rubicon Research Ltd’s net profit jumped 91.23% since last year same period to ₹72.80Cr in the Q3 2025-2026. On a quarterly growth basis, Rubicon Research Ltd has generated 35.19% jump in its net profits since last 3-months.

    Read More about Earnings Results

Indices Featuring Rubicon Research Stock

Check stock indices that include Rubicon Research.

BSE IPO

₹15,354.78

2.49 (▲372.78%)

BSE Healthcare

₹42,619.40

0.49 (▲209.78%)

Insights on Rubicon Research Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 5.37% to 7.99% in Dec 2025 quarter

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 20.10% to 22.57% in Dec 2025 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, RUBICON stock has moved up by 26.9%

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 5.63% to 6.61% in Dec 2025 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 59.99% of holdings in Dec 2025 quarter

About Rubicon Research Ltd

Rubicon Research Limited was incorporated on May 6 1999 as a Private Limited Company under the name Rubicon Consultants Private Limited issued by the RoC. Subsequently the Company name was changed from Rubicon Consultants Private Limited to RubiconResearch Private Limited consequent to which a fresh Certificate of Incorporation was issued by the RoC dated September 2 2002. The Companys status converted from a Private Limited Company to a Public Limited Company the name was changed from Rubicon Research Private Limited to Rubicon Research Limited. A fresh Certificate of Incorporation dated July 23 2024 was issued bythe Registrar of Companies Central Processing Centre Manesar Haryana consequent to Companys conversion into a Public Limited Company.Rubicon Research is an integrated pharmaceutical company with business encompassing the entire value chain in the research development and production of pharmaceutical products. The Company is driven by innovation through focused research and development with an increasing portfolio of specialty products and drugdevice combination products targeting regulated markets particularly the United States. It has obtained its GMP manufacturing facilities at Ambernath and Satara in Maharashtra.The Company commenced manufacturing of certain special drugs in Ambernath Manufacturing Facility in 2011. In 2016 the Company acquired majority stake by ECP III Pte Ltd. Further it acquired majority stake by General Atlantic Singapore RR Pte. Ltd. from ECP III Pte. Ltd. in 2019. In 2021 the Company acquired the business of Meditab Specialities Limited on slump sale as a going concern. In 2024 the Company acquired Validus a New Jersey headquartered marketer of brand name formulation products in the US. Validus has twobrand name products in the CNS therapy area Equetro and Marplan. The Company is planning to raise money from public through IPO aggregating to Rs 1085 Crores consisting Rs 500 Crore Fresh Issue Equity Shares and an Offer for Sale of Rs 585 Crore Equity Shares..

Revenue: ₹475.53Cr as on December 2025 (Q3 FY26)
Net Profit: ₹72.80Cr as on December 2025 (Q3 FY26)
Listing date: 16 Oct, 2025
Chairperson Name: K G Ananthakrishnan
OrganisationRubicon Research Ltd
IndustryPharmaceuticals
CEOK G Ananthakrishnan
E-voting on sharesClick here to vote

FAQs

What is Rubicon Research share price today?

Rubicon Research share price today stands at ₹836.1 as on at the close of the market. Rubicon Research share today touched a day high of ₹885.8 and a low of ₹830.25.

What is the 52 week high and 52 week low range for Rubicon Research share?

Rubicon Research touched a 52 week high of ₹885.8 and a 52 week low of ₹570.75. Rubicon Research share price today i.e. is closed at ₹836.1, which is -5.61% down from its 52 week high and 46.49% up from its 52 week low.

What is Rubicon Research's market capitalisation today?

Rubicon Research market capitalisation is ₹14,105.92 Cr as on .

How to buy Rubicon Research shares?

To buy Rubicon Research shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for RUBICON or Rubicon Research Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Rubicon Research shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Rubicon Research trading volume today?

Rubicon Research trading volume is 5.77L as on . This means that 5.77L shares of Rubicon Research were bought and sold on the stock market during today's trading session.